Home > Insider Trading > Filing (0001209191-15-009201)

Filing Details

Accession Number:: 0001209191-15-009201
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-02-03 21:00:13
Reporting Period:: 2015-01-30

Filing Date:: 2015-02-03
Accepted Time:: 2015-02-03 21:00:13
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
69499	Mylan Inc.	MYL	Pharmaceutical Preparations (2834)	251211621

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1197543	J Robert Coury	1000 Mylan Blvd Canonsburg PA 15317	Executive Chairman	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-01-30	258,564	$21.13	1,535,254	No	4	M	Direct
Common Stock	Disposition	2015-01-30	258,564	$53.73	1,276,690	No	4	S	Direct
Common Stock	Acquisiton	2015-02-02	130,203	$21.13	1,406,893	No	4	M	Direct
Common Stock	Acquisiton	2015-02-02	273,912	$22.66	1,680,805	No	4	M	Direct
Common Stock	Disposition	2015-02-02	404,115	$52.87	1,276,690	No	4	S	Direct
Common Stock	Acquisiton	2015-02-03	51,903	$22.66	1,328,593	No	4	M	Direct
Common Stock	Acquisiton	2015-02-03	181,035	$23.44	1,509,628	No	4	M	Direct
Common Stock	Acquisiton	2015-02-03	51,502	$30.90	1,561,130	No	4	M	Direct
Common Stock	Disposition	2015-02-03	284,440	$51.01	1,276,690	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option - Right to Buy	Disposition	2015-01-30	258,564	$0.00	258,564	$21.13
Common Stock	Employee Stock Option - Right to Buy	Disposition	2015-02-02	130,203	$0.00	130,203	$21.13
Common Stock	Employee Stock Option - Right to Buy	Disposition	2015-02-02	273,912	$0.00	273,912	$22.66
Common Stock	Employee Stock Option - Right to Buy	Disposition	2015-02-03	51,903	$0.00	51,903	$22.66
Common Stock	Employee Stock Option - Right to Buy	Disposition	2015-02-03	181,035	$0.00	181,035	$23.44
Common Stock	Employee Stock Option - Right to Buy	Disposition	2015-02-03	51,502	$0.00	51,502	$30.90

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
144,399	2020-03-03	No	4	M	Direct
14,196	2020-03-03	No	4	M	Direct
56,316	2021-03-02	No	4	M	Direct
4,413	2021-03-02	No	4	M	Direct
4,266	2022-02-22	No	4	M	Direct
3,236	2023-03-06	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,957	Indirect	By 401(k) Plan

Footnotes

Represents acquisition of Mylan common stock upon exercise of stock options granted on March 3, 2010.
Represents the weighted average price of shares sold by the broker on behalf of certain non-employee directors and executive officers of Mylan on January 30, 2015. The broker sold, in the aggregate on behalf of such non-employee directors and executive officers, 403,595 shares in transactions ranging from $53.01 to $54.00 with a weighted average price of $53.5684 as well as 205,341 shares in transactions ranging from $54.005 to $54.25 with a weighted average price of $54.0425. The proceeds of all such sales were allocated to the applicable non-employee directors and executive officers on a pro rata basis based on the number of shares sold by such person.
Represents acquisition of Mylan common stock upon exercise of stock options granted on March 2, 2011.
Represents the weighted average price of shares sold by the broker on behalf of certain non-employee directors and executive officers of Mylan on February 2, 2015. The broker sold, in the aggregate on behalf of such non-employee directors and executive officers, 937,763 shares in transactions ranging from $52.23 to $53.22 with a weighted average price of $52.8646 as well as 13,957 shares in transactions ranging from $53.23 to $53.745 with a weighted average price of $53.5027. The proceeds of all such sales were allocated to the applicable non-employee directors and executive officers on a pro rata basis based on the number of shares sold by such person.
Represents acquisition of Mylan common stock upon exercise of stock options granted on February 22, 2012.
Represents acquisition of Mylan common stock upon exercise of stock options granted on March 6, 2013.
Represents the weighted average price of shares sold by the broker on behalf of certain non-employee directors and executive officers of Mylan on February 3, 2015. The broker sold, in the aggregate on behalf of such non-employee directors and executive officers, 520,475 shares in transactions ranging from $52.50 to $53.25 with a weighted average price of $52.8739 as well as 149,400 shares at $53.50 and 1 share at $54.50. The proceeds of all such sales were allocated to the applicable non-employee directors and executive officers on a pro rata basis based on the number of shares sold by such person.
This option exercise and the related sale of the underlying common stock were executed pursuant to a 10b5-1 trading plan dated November 9, 2014.
These options vested in three equal installments on March 3, 2011, 2012, and 2013.
These options vested in three equal installments on March 2, 2012, 2013, and 2014.
Two thirds of these options vested in equal installments on February 22, 2013 and 2014.
One third of these options vested on March 6, 2014.